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Skeletal muscle ventricles were constructed from the latissimus dorsi in six dogs by wrapping the 
muscle around a polypropylene mandrel. Jugular vein endothelial cells were harvested enzymatically 
and grown in tissue culture. After 3 weeks of vascular delay and 4 weeks of electrical conditioning, 
five skeletal muscle ventricles were seeded with 5 to 8 x 106 autologous endothelial cells by 
percutaneous injection of a cellular suspension i to the lumen of the skeletal muscle ventricle; one 
skeletal muscle ventricle was injected with culture medium alone as an unseeded control. The 
autologous endothelial cells were all prelabeled with a lipid-bound cellular marker, PKH-26. After 
an additional 4weeks of electrical conditioning, the mandrels were removed and the skeletal muscle 
ventricles were connected to the descending thoracic aorta and activated to contract during cardiac 
diastole at a 1:2 ratio with the heart. After 3 hours of continuous pumping, mean diastolic pressure 
was increased by 35% (58 - 7 versus 78 - 6 mm Hg, p < 0.05). At this time, the skeletal muscle 
ventricles were excised for histologic examination. Sections stained with hematoxylin and eosin 
revealed a continuous cellular layer lining the skeletal muscle ventricle; no cells were present on the 
lumen of the control skeletal muscle ventricle. All seeded skeletal muscle ventricles exhibited 
fluorescence as a result of the PKH-26 cellular marker. Immunofluorescent staining with antibodies 
to von Willebrand factor and ultrastructural nalysis with an electron microscope confirmed the 
endothelial character of these cells lining the lumen of the skeletal muscle ventricles. The ability to 
create endothelial cell-lined muscular pumping chambers holds important implications for the 
resolution of thrombotic events in cardiac assist devices as well as toward the clinical application of 
skeletal muscle ventricles. (J THORAC CARDIOVASC SURG 1995;109:66-73) 
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Although several investigators have wrapped skele- 
tal muscle directly around the heart for cardiac 
assist, we have worked toward developing separate 
pumping chambers from skeletal muscle, termed 
skeletal muscle ventricles, or SMVs. One of the 
difficulties encountered uring long-term studies of 
SMVs in circulation has been the development of 
thrombus inside the SMV. 1-3 The two biggest factors 
involved in SMV thrombosis are the flow character- 
istics and the blood-surface interactions within the 
SMV cavity. An  endothelial monolayer might de- 
crease the likelihood of thrombosis by providing 
nature's own antithrombotic surface. In previous 
s tud ies ,  we  4-6 have demonstrated the feasibility of 
seeding the surfaces of SMVs with endothelial cells. 
The purpose of this study was to determine whether 
autogenously seeded, endothelial cell-l ined SMVs 
could retain this lining while actively pumping blood 
in the systemic irculation. 
Materials and methods 
SMV construction. SMVs were constructed from the 
latissimus dorsi muscle in six dogs as previously de- 
scribed. 7All animals were operated on in accordance with 
the "Principles of Laboratory Animal Care" formulated 
by the National Society for Medical Research and the 
"Guide for the Care and Use of Laboratory Animals!' 
prepared by the Institute of Laboratory Animal Resources 
and published by the National Institutes of Health (NIH 
publication No. 85-23, revised 1985). In brief, the latissi- 
mus dorsi muscle was mobilized except for its neurovas- 
cular pedicle and humeral insertion. A nerve lead was 
placed around the thoracodorsal nerve and connected to 
a neurostimulator (Itrel, Medtronic Inc., Minneapolis, 
Minn.). The muscle was wrapped approximately two times 
around a synthetic, polypropylene mandrel. At the same 
time, the jugular vein was excised and placed in 50 ml of 
a phosphate-buffered saline solution with 4 to 5 ml of 
oxygenated blood and 2000 units of sodium heparin at 
37 ° C for later harvesting. The neurostimulator was buried 
under the left rectus muscle, all wounds were closed in 
layers, and the animals recovered. 
Endothelial cell culture. Autologous endothelial cells 
were harvested from the jugular vein with 0.1% collage- 
nase and gentle scraping. Contaminants were removed by 
flow-cytometric sorting with the endothelial cell-specific 
marker 1,1,-dioctadecyl-3,3,3',3' tetramethylnidocarbo- 
cyanine-perchlorate (diI)-acetylated low-density lipopro- 
s tein. The purified, autologous endothelial cell population 
was frozen in 10% dimethyl sulfoxide at -80°C  and 
stored at - 196 ° C. After 4 weeks, the cells were thawed 
and reconstituted in Dulbecco's modified Eagle's medium 
supplemented with 10% fetal calf serum, L-glutamine 
(2 mmol/L), and antibiotics. The cells were maintained in 
a 5% carbon dioxide incubator at 37 ° C and underwent a 
total of three to five passages in culture until a total of 5 
to 8 x 10 6 cells per animal were available for seeding. 
Endothelial cell seeding. While the endothelial cells 
were being cultured, the animal's SMV underwent a 
3-week vascular delay followed by a 4-week period of 
electrical conditioning at 2 Hz. This regimen has been 
shown to transform the muscle to a fatigue-resistant 
state. 9 After this 7-week period, the animals underwent 
seeding by percutaneous injection of a solution (5 x 108 
cells per animal) containing each animal's autologous 
endothelial cells suspended in 5 ml of Dulbecco's modi- 
fied Eagle's medium. Immediately before seeding, the 
pure endothelial cell population was prelabeled with a 
lipid-bound marker, PKH-26. This marker has been pre- 
viously demonstrated to be a reliable cellular label to track 
cells in vivo. a° The cells were then injected into the space 
adjacent to the mandrel around which the latissimus 
muscle had been wrapped. Several injection sites were 
used to help ensure uniformity of seeding. One animal 
underwent injection of Dulbecco's modified Eagle's me- 
dium only as an unseeded control. The neurostimulator 
was temporarily turned off during the seeding process. 
Hemodynamic measurements. One week after seeding, 
the neurostimulators were reactivated at 2 Hz and condi- 
tioning was continued for an additional 3 weeks. At the 
conclusion of this time (4 weeks from seeding, 11 weeks 
from construction), the animals were reanesthetized and 
the chest was opened via a lateral thoracotomy. The 
mandrel was carefully removed from the SMV and the 
SMV was anastomosed to the descending thoracic aorta 
with two polytetrafluoroethylene grafts. The nerve lead 
was attached to a cardiomyostimulator (Prometheus, 
Medtronic Inc.) and two myocardial sensing electrodes 
were placed on the heart. The stimulator was set at a 33 
Hz burst frequency at a 1:2 contraction ratio with the 
heart. The burst delay was set at 40% with a burst 
duration of 45% of the R-R interval. Aortic and left 
ventricular pressures were recorded with 5F microtrans- 
ducer-tipped catheters po itioned at the time of the 
operation. Hemodynamic recordings were taken at the 
time of connection to the circulation and hourly for 3 
hours. 
Histologic examination. After 3 hours of continuous 
pumping in circulation, the animals were killed and the 
SMVs carefully excised. The SMVs were washed gently in 
saline solution, and the surface was then fixed in situ with 
Karnovsky's fixative for 20 minutes at room temperature; 
the SMVs were subsequently fixed in formalin at 4 ° C for 
24 hours. The luminal surface was divided into three 
areas: top, middle, and apex (bottom). After initial exam- 
ination for gross evidence of thrombosis or damage to the 
luminal surface, at least six random segments, approxi- 
mately 1 cm z each, were excised from the three different 
portions. All samples were coded and then processed and 
evaluated in a blinded fashion as to the state of endothe- 
lialization of the sections. Two samples from each seg- 
ment were processed for conventional histologic examina- 
tion (hematoxylin and eosin staining), and two were 
analyzed en face as whole mounts by fluorescence micros- 
copy with PKH-26 and von Willebrand factor (vWF). The 
remaining samples were set aside for electron microscopy. 
Sections tained with hematoxylin and eosin were ana- 
lyzed qualitatively for the presence or absence of a 
contiguous monolayer of cells with a standard light micro- 
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Fig. 1. Representat ive pressure trace taken from an animal with an endothelial ized SMV in circulation for 
3 hours. Diastolic augmentat ion oted by dots in carotid and femoral traces. Cardiomyostimulator 
contracting at a 1:2 ratio with the heart  at 33 Hz burst frequency. EKG, Electrocardiogram. 
Tab le  I. Hemodynamic assessment o f  endothelial cell-lined SMV aortic counterpulsation 
Initial One hour Two hours Three hours 
Parame~r Off On Off On Off On Off On 
Heart rate (beats/min) 107 -2_ 8 107 + 8 107 --- 9 107 + 9 114 -+ 8 114 -4- 8 114 -+ 7 114 - 7 
BPsYs (mm Hg) 80.3 +- 5.1 76.5 - 7.6 83.4 --- 7.2 82.9 --- 7.2 82.7 -+ 5.7 82.0 _+ 5.5 78.2 -2_ 5.5 76.9 - 5.7 
BPDIA (ram Hg) 58.6 4- 5.1 78.1 - 5.8* 62.4 --- 7.7 80.8 --- 6.4* 61.6 - 5.8 80.8 -+ 6.4* 58.3 -+ 7.1 78.2 - 6.2* 
BPPRESYSTOLE 54.3 "4- 4.9 45.3 --+ 5.5* 58.1 ----- 7.9 51.9 -- 8.9 57.2 -- 6.4 48.6 -- 7.6* 53.7 ----- 6.3 48.7 + 7.0 
TTI (mm Hg'  sec) 16.7 --- 0.9 15.2 -+ 1.1" 16.2 _+ 0.6 15.2 _+ 2.6 15.8 +- 1.1 15.1 +- 1.4 14.2 -+ 1.1 13.8 -+ 1.3 
DPTI (mm Hg. sec) 19.9 -+ 1.5 23.2 -+ 2.1" 21.0 _+ 2.1 25.7 _+ 2.0* 19.3 +- 2.0 23.5 +- 2.8* 18.2 --- 1.7 21.8 +- 1.9" 
EVR (DPTIFFTI) 1.19 + 0.06 1.52 _+ 0.09* 1.27 _+ 0.09 1.71 _+ 0.01" 1.24 + 0.14 1.61 +-- 0.55 1.28 - 0.14 1.67 +_ 0.11" 
Diastolic augment (%) NA 33.2 +- 8.3 NA 29.5 -+ 10.1 NA 31.2 +- 9.0 NA 34.1 4- 6.0 
BPsYs, Peak systolic carotid pressure; BPD~, mean diastolic carotid pressure; BPeReSrSrOLe, minimum diastolic carotid pressure; TT/, systolic tension time 
index; DPTI, diastolic tension time index; EVR, endocardial viability ratio; diastolic augment, [BPD~A (on) -- BPDIA (Off)]/BPD/A; NA, not applicable. 
*p < 0.05 (analysis of variance), pacer offversus on (n = 6). 
scope. Fluorescence staining of the en face blocks was 
viewed with a low light-level video camera (Hamamatsu 
Photonics KK, Shizuoka, Japan) and digitized into a 
TN8500 image analyzer (Noran Instruments, Middleton, 
Wis.), with the red, rhodamine-f luorescence filter used for 
PKH-26 fluorescence. Background autofluorescence was 
determined by using the unseeded, control SMV as a zero 
reference. 
The en face whole mount  segments were then stained 
immunofluorescently with labeled antibodies to vWF. The 
sections were incubated with a rabbit-derived 1:100 dilu- 
t ion of polyclonal vWF antibody. Bovine serum albumin 
(0.1%) was used to block nonspecific binding. A 1:1000 
dilution antirabbit immunoglobul in G labeled with fluo- 
rescein isothiocyanate (FITC) was then used to label the 
vWF antibody. Sections were viewed with fluorescein 
excitation and the green, FITC-f luorescent filter was used. 
Fi ltered images were digitized with the TN8500 image 
analyzer as described earlier, again with the autofluores- 
cence of the unseeded SMV used as a control. 
From each of these tissue samples (light and fluorescent 
microscopy), three random areas were photographed and 
evaluated. With the use of the en face mounts with 
PKH-26 and vWF staining, the percent surface coverage 
of endothel ial  cells over the SMV luminal surface was 
determined by analyzing the confluency of cellular fluo- 
rescence compared with the total area. After evaluations 
were compiled, the experimental results were correlated 
with the sample identification, seeding state, and location 
of sample to determine the total percent cellular coverage 
for each seeded SMV. 
Random sections of one of the seeded SMVs and also 
from the unseeded SMV were prepared and submitted for 
examination with an electron microscope. 
Results 
I - Iemodynamies .  Hemodynamic  va lues  for  all six 
an imals  over  the  3 -hour  per iod  are inc luded in 
Tab le  I. The  SMVs  funct ioned  wel l  th roughout  the  
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Fig. 2. Photomicrograph of the luminal surface of seeded SMV after incubation with immunofluorescent 
antibodies to vWF. Presence ofvWF staining identifies cells lining the SMV lumen as endothelial in nature. 
(Original magnification ×650.) 
3 hours of continuous pumping; mean diastolic 
pressure was augmented 35% at the conclusion of 
the experiment (58 _ 7 versus 78 _+ 6 mm Hg, p < 
0.05). A representative pressure tracing from one 
animal is shown in Fig. 1. 
Light microscopy. Light microscopy with hema- 
toxylin and eosin staining revealed a continuous 
cellular layer present in each of the seeded SMVs. 
The cellular layer appeared to be most confluent at 
the apex of the SMV, and there were few cells within 
a 5 mm zone from the SMV base, adjacent to the 
Dacron sewing ring. No cells were seen lining the 
surface of the unseeded SMV. Rather, a fibrous 
layer of noncellular elements was seen in the un- 
seeded SMV. 
Fluorescent microscopy. Fluorescent microscopy 
revealed fluorescence resulting from the PKH-26 
marker in all seeded SMVs. Photographic evalua- 
tion of the video images obtained from the T8500 
analyzer showed that the fluorescence was cellular 
in nature. In contrast, no cellular elements were 
noted in the unseeded SMV, only background 
autofluorescence from the tissues fixed in glutaral- 
dehyde and formaldehyde. 
Immunofluorescent staining with vWF antibodies 
also showed endothelial cells lining the SMV lumen. 
Histologically, the vWF-labeled fluorescent sections 
appeared similar to those obtained with PKH-26. A 
vWF-labeled segment from a representative section 
of an SMV surface is shown in Fig. 2. In comparing 
Table II. Quantitative assessment of endothelial 
monolayer 
EC confluency EC confluency 
Section by PKH-26 by vWF 
of SMV (%) (%) 
Center  52.3 _+ 7.3 63.2 -4- 14.7 
Apex 68.4 _+ 12.6 78.8 -4- 8.9 
EC, Endothelial cells (n = 5), 
determinations of percent endothelial cell coverage 
of the SMV lumen from both PKH-26 and vWF, we 
noted a trend toward increased percentage of cov- 
erage when cells were stained with vWF. The per- 
centage of coverage of endothelial cells for both 
PKH-26 fluorescence and vWF immunofluores- 
cence is shown in Table II. 
Scanning electron microscopy of the luminal sur- 
face of the unseeded SMV revealed arough, fibrous 
surface with numerous platelets and other blood 
elements attached to the fibrous surface (Fig. 3), In 
contrast, scanning electron micrographs of the 
seeded SMV revealed a smooth, cellular surface 
with few blood elements adherent (Fig. 4). When 
these cells were viewed under a high-power trans- 
mission electron microscope, ultrastructural charac- 
teristics of endothelial cells such as tight intercel- 
lular junctions and Weibel-Palade bodies were 
apparent, helping to confirm the endothelial nature 
of the cells lining the SMV lumen. 
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Fig. 3. Scanning electron micrograph of the luminal surface of the unseeded (control) SMV (original 
magnification ×500). The luminal surface is rough and multiple layers of fibers are seen along the surface. 
Platelets and other blood elements can be seen adherent to the SMV wall. 
Fig. 4. Scanning electron micrograph of the luminal surface of a seeded SMV (original magnification 
×470). In contrast to the seeded SMV, a smooth, cellular lining is present. Only minimal platelet 
deposition can be seen on the surface of the SMV. 
Discussion 
Over the past several years, we have worked 
toward developing autogenous muscle pumping 
chambers (SMVs) for cardiac assist. In early in- 
circulation studies, thrombus formation was prob- 
lematic; the incidence of thrombus formation was 
nearly 100% and embolism occurred in 33% of 
animals, u Improvements in SMV design and con- 
figuration have improved the incidence of thrombo- 
sis but have not eliminated it altogether. In one 
recent study, Nakajima and associates i2 noted a 
54.5% incidence of thrombus formation inside the 
SMV, although the incidence of embolism was only 
5%. 
In an effort to further decrease or eliminate the 
risk of SMV thrombosis and embolism, we 5' 6 have 
previously demonstrated the ability to successfully 
seed SMVs with endothelial cells using the same 
techniques as described herein. The clinical effec- 
tiveness of endothelial cell seeding for decreasing 
The Journal of Thoracic and 
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the likelihood of thrombosis was first demonstrated 
by Herring, Gardner, and Glover 13 in 1978. They 
reported a threefold ecrease in the thrombosis of 
endothelialized vascular grafts compared with un- 
seeded control grafts. The mechanism by which 
endothelial cells promote an antithrombogenic en- 
vironment is not fully understood but appears to be 
a balance of procoagulant and anticoagulant activi- 
ty. 14 With regard to anticoagulant activity, endothe- 
lial cells have been shown to bind antithrombin III, 
locally inhibiting the coagulation cascade, aS' 16 En- 
dothelium also inhibits platelet aggregation through 
prostaglandin 12 productionF actor IXa is also 
modulated by the endothelial cell to effect coagulant 
homeostasis. 
The endothelial character of the cells lining the 
seeded SMVs was confirmed by specific stains, as 
well as morphologic haracteristics. Hematoxylin 
and eosin staining demonstrates the pr sence of a 
continuous, ingle monolayer of cells. However, this 
is only suggestive for endothelial cells. The presence 
of PKH-26 fluorescence indicates that the cells 
lining the SMV lumen are either the originally 
seeded cells or their direct progeny. PKH-26 is an 
established marker that has been used to trace the 
fate of cells in vivo. In a rabbit model, this lipid- 
bound fluorescent label has been shown to remain 
bound to red blood cells in vitro for more than 60 
days. 1° In previous studies, we 6 have shown that 
PKH-26 can be identified in seeded cells for at least 
3 weeks in vivo, whereas in vitro the marker is 
traceable for more than 20 population doublings 
over a period of 6 weeks. 
Immunofluorescent stains with antibodies to vWF 
have been shown to specifically bind to endothelial 
cells. 18 In this study, the percentage of coverage of 
the SMV luminal surface was greater with vWF than 
with PKH-26. In earlier studies, we ~9 have ad- 
dressed the differences seen in the number of cells 
containing PKH-26 and other endothelial markers, 
such as vWF, diI-acetylated low-density lipoprotein. 
Although there may be a loss of PKH-26 fluores- 
cence, it is also possible that either the seeding 
process or else the presence of endothelial cells pro- 
vides chemotactic orangiogenic factors inducing the 
growth of autogenous endothelial cells from another 
(nonseeded) source into the SMV lumen. In the 
prior study, close examination of the basement 
membrane l vel of seeded SMVs showed numerous 
subluminal blood vessels when compared with un- 
seeded controls, supportive of possible ingrowth of 
endothelial cells from an unseeded source. 19 
One of the objectives of this current study was to 
determine if a monolayer of endothelial cells could 
be retained under in vivo shear stress conditions 
present in an actively contracting ventricle. In our 
previous tudies, in which SMVs were not used to 
pump blood in the circulation, an 80% to 100% 
monolayer of cells was obtained along the luminal 
surface. 6 This monolayer emained intact during 
electrical stimulation ecessary to achieve fatigue 
resistance. The decrease in the percent endothelial 
coverage of the SMV luminal surface between the 
previous tudy (80% to 100%) and this current study 
(50% to 80%) may be related to the effects of shear 
stress on the endothelium. In vivo studies of seeded 
vascular prostheses demonstrate significant loss of 
endothelial cells during pulsatile flow. 2°' 21 In those 
studies, most of the cell loss was within the first 1 to 
2 hours. Although additional cell loss may occur as 
a result of shear stress beyond the first 3 hours, prior 
studies with vascular prostheses uggest hat the 
remaining cells would likely remain adherent. 22The 
fact that the endothelial cells in this experiment 
were seeded onto a collagenous, fibrous surface 
rather than a synthetic one would likely serve to 
increase ndothelial retention during shear stress. In 
fact, modification of synthetic grafts with matrix 
proteins uch as collagen or fibronectin are used for 
improving endothelial retention. 23' 24
Alternatively, the decrease in endothelial cover- 
age may be related to mechanical trauma to the 
lining while the SMV is being placed in circulation. 
The thin, endothelial monolayer is extremely sensi- 
tive to atmospheric exposure or handling. Few cells 
were seen at the SMV base, within 5 mm of the 
sewing ring, whereas the SMV apices were invari- 
ably covered with a monolayer of cells. This obser- 
vation suggests hat the base may have been partially 
denuded of endothelial cells during the process of 
removing the SMV mandrel and anastomosing the 
SMV to the polytetrafluoroethylene graft. Although 
an incomplete monolayer may be thrombogenic, the 
possibility exists for continued growth of the apical 
monolayer to cover the denuded strip toward the 
sewing ring. Additionally, we have noted in prior 
studies that clot generally develops initially at the 
apex of the SMV, which is where the maximal 
confluent coverage of the SMV occurred. 12 
This study indicates that, over a 3-hour period, 
endothelial cell-lined SMVs can effectively function 
in the systemic irculation while retaining their 
endothelial monolayer. To our knowledge, this is 
the first time that an autogenous endothelial cell-
7 2 Thomas et al. 
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lined cardiac assist device has retained endothelium 
while functioning in the systemic irculation. One 
previous report has demonstrated that endothelial 
cells can be cultured from the linings of ventricular 
assist devices. 25 However, those findings differ from 
the current experiment in that the autogenous cells 
in this experiment were specifically seeded onto the 
surface to affect thrombogenicity. 
The existence of an endothelialized contractile 
pump holds great implications for the decreasing 
thromboembolic events in both mechanical and 
skeletal muscle-powered assist devices. It remains 
to be seen whether these endothelialized SMVs will 
markedly change the current high incidence of 
thrombosis associated with SMVs in circulation. 
Resolution of thrombosis and subsequent embolism 
will bring SMVs nearer to eventual clinical applica- 
tion. 
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Discussion 
Mr. John H. Kennedy (Cambridge, England). You are 
to be congratulated for this novel approach to the ever- 
lasting problem of lining an artificial ventricle of one sort 
or another with something so that thrombosis will not 
occur. Could you comment on what the likely life span of 
your newly seeded endothelial cells would be? 
Dr. Thomas. That is something we are going to have to 
define in further studies. We have been able to show in 
preliminary experiments that these cells are viable and 
have been present inside the SMVs for more than about a 
month, because the seeding process is done in the middle 
of the conditioning process for the SMVs. 
We currently are looking at 2-week and 2-month in- 
circulation studies, but I cannot comment on whether ~ve 
will actually find the endothelial cells inside the SMVs at 
that time. If we do, then we hope that this will help to 
decrease the problem with thrombosis that has been 
present in prior series. 
Dr. Yasuharu Noishiki (Yokohama, Japan). With a 
vascular prosthesis, a fully endothelialized surface is rare. 
Most seeded endothelial cells cannot survive in vivo. But 
a certain number of cells are needed on the surface for 
these cells to survive further. For example, in case of 
cancer cells, more than 50 cells are required to make a 
new colony, namely, a new metastasis. 
To enhance the endothelialization, I reported a method 
to accelerate ndothelialization of vascular prostheses 
with autologous tissue fragment ransplantation at the 
annual meeting held in Los Angeles. One of the research 
groups in Osaka already reported a successful result using 
my method in vivo, and a complete ndothelialized sur- 
face was demonstrated in an experiment similar to that 
which you did. 
Their paper was already reported in the Japanese 
Society of Artificial Organs; therefore, I am afraid that your 
experiment is not the first case of endothelialization. 
My question is this: How high is the survival rate of the 
endothelial cells and what is the mechanism for the good 
endothelialization in your experiment? 
Dr. Thomas. In this experiment we used endothelial 
cells that were grown in tissue culture so that we could 
obtain high numbers at the time of seeding. Some of the 
series involving the seeding of vascular grafts have ob- 
tained endothelial cells enzymatically from either the 
jugular vein or other sources directly at he time of 
seeding; those methods generally have not been able to 
produce a sufficient number of cells for seeding a very 
large area such as the inner lining of a ventricular assist 
device or an SMV. We have generally used between 5 
million and 8 million cells grown in tissue culture for 
seeding purposes. 
Further studies will be necessary to determine the 
long-term survival of these cells. We are conducting a
number of preliminary studies in which we are trying to 
line a static or noncontracting SMV. At 2 weeks we 
usually have around 50% coverage of the SMV. These 
cells continue to grow and populate the undersurface of 
the SMV until at 4 to 6 weeks coverage is 100%. 
We had a slight decrease in percent coverage in this 
series, probably because of manipulation when the SMV 
was being put into the circulation. As you recall, there 
were very few cells next to the Teflon sewing ring that we 
used to construct he anastomosis, whereas down at he 
apex there is a great confluency of cells. 
Whether this trend will continue as the SMVs are in 
circulation for longer periods remains to be seen, but 
many of the kinetic studies that have shown loss of 
endothelial cells in vascular grafts show that the great 
majority are lost in the first several hours when they are 
first in circulation. After 24 to 48 hours this tends to 
stabilize and the cells can then continue to slowly grow 
and repopulate the surface. 
